Search Results for: LYN

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
PAK2 p21 (RAC1) activated kinase 2
  • Nef and signal transduction
  • Generation of second messenger molecules
  • Regulation of PAK-2p34 activity by PS-GAP/RHG10
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • Stimulation of the cell death response by PAK-2p34
  • FCERI mediated MAPK activation
  • FCERI mediated MAPK activation
  • CD28 dependent Vav1 pathway
  • Ephrin signaling
  • Sema3A PAK dependent Axon repulsion
  • Activation of RAC1
  • VEGFA-VEGFR2 Pathway
  • Smooth Muscle Contraction
  • VEGFR2 mediated vascular permeability
  • CD209 (DC-SIGN) signaling
  • RHO GTPases activate PAKs
  • RHO GTPases activate PAKs
  • MAPK6/MAPK4 signaling
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • Fostamatinib
PDE4A phosphodiesterase 4A
  • DARPP-32 events
  • G alpha (s) signalling events
  • Caffeine
  • Theophylline
  • Dyphylline
  • Enprofylline
  • Dipyridamole
  • Iloprost
  • Oxtriphylline
  • Amrinone
  • Roflumilast
  • Piclamilast
  • Crisaborole
  • Ibudilast
  • Propentofylline
  • Drotaverine
  • (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one
  • 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
  • Tofisopam
  • Trapidil
PDE4D phosphodiesterase 4D
  • DARPP-32 events
  • G alpha (s) signalling events
  • Adenosine phosphate
  • Caffeine
  • Caffeine
  • Dyphylline
  • Iloprost
  • Amrinone
  • Roflumilast
  • Piclamilast
  • Rolipram
  • 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol
  • Zardaverine
  • 1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • (S)-Rolipram
  • Cilomilast
  • (R)-Rolipram
  • 3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • 1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • Crisaborole
  • Ibudilast
  • Tetomilast
  • Exisulind
  • (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one
  • 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
  • 3-isobutyl-1-methyl-7H-xanthine
  • 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
  • Trapidil
PECAM1 platelet and endothelial cell adhesion molecule 1
  • Platelet degranulation
  • Cell surface interactions at the vascular wall
  • PECAM1 interactions
  • Integrin cell surface interactions
  • Platelet sensitization by LDL
  • Neutrophil degranulation
PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
  • GPVI-mediated activation cascade
  • Synthesis of PIPs at the plasma membrane
  • G beta:gamma signalling through PI3Kgamma
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Staurosporine
  • Myricetin
  • LY-294002
  • Quercetin
  • 5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE
  • XL765
  • TG100-115
  • 2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE
  • N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide
  • 5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one
  • 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL
  • (5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE
  • Wortmannin
  • 1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • Duvelisib
  • Fostamatinib
PILRB paired immunoglobin like type 2 receptor beta
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
PLCG1 phospholipase C gamma 1
  • ISG15 antiviral mechanism
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • PLCG1 events in ERBB2 signaling
  • DAG and IP3 signaling
  • PLC-gamma1 signalling
  • Synthesis of IP3 and IP4 in the cytosol
  • Downstream signal transduction
  • Generation of second messenger molecules
  • Role of phospholipids in phagocytosis
  • Role of phospholipids in phagocytosis
  • PECAM1 interactions
  • EGFR interacts with phospholipase C-gamma
  • DAP12 signaling
  • FCERI mediated MAPK activation
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Role of second messengers in netrin-1 signaling
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated cell proliferation
  • Constitutive Signaling by EGFRvIII
  • Phospholipase C-mediated cascade: FGFR1
  • Phospholipase C-mediated cascade; FGFR2
  • Phospholipase C-mediated cascade; FGFR3
  • Phospholipase C-mediated cascade; FGFR4
  • Signaling by FGFR2 in disease
  • Signaling by FGFR4 in disease
  • Signaling by FGFR1 in disease
  • Signaling by FGFR3 point mutants in cancer
  • RET signaling
  • Activated NTRK2 signals through PLCG1
  • Activated NTRK2 signals through PLCG1
  • Erythropoietin activates Phospholipase C gamma (PLCG)
  • Activated NTRK3 signals through PLCG1
  • Activated NTRK3 signals through PLCG1
  • FCGR3A-mediated IL10 synthesis
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
PLCG2 phospholipase C gamma 2
  • GPVI-mediated activation cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Synthesis of IP3 and IP4 in the cytosol
  • Generation of second messenger molecules
  • Role of phospholipids in phagocytosis
  • DAP12 signaling
  • FCERI mediated MAPK activation
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • CLEC7A (Dectin-1) signaling
  • CLEC7A (Dectin-1) signaling
  • Dectin-2 family
  • Dectin-2 family
  • Erythropoietin activates Phospholipase C gamma (PLCG)
  • FCGR3A-mediated IL10 synthesis
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
PPP1R15A protein phosphatase 1 regulatory subunit 15A
  • Downregulation of TGF-beta receptor signaling
  • Response of EIF2AK1 (HRI) to heme deficiency
PPP1R8 protein phosphatase 1 regulatory subunit 8
PRAM1 PML-RARA regulated adaptor molecule 1
PRKCD protein kinase C delta
  • Apoptotic cleavage of cellular proteins
  • Calmodulin induced events
  • Effects of PIP2 hydrolysis
  • SHC1 events in ERBB2 signaling
  • DAG and IP3 signaling
  • Role of phospholipids in phagocytosis
  • G alpha (z) signalling events
  • HuR (ELAVL1) binds and stabilizes mRNA
  • VEGFR2 mediated cell proliferation
  • CLEC7A (Dectin-1) signaling
  • RHO GTPases Activate NADPH Oxidases
  • Neutrophil degranulation
  • Interferon gamma signaling
  • Tamoxifen
  • 13-Acetylphorbol
  • Ingenol mebutate
  • Fostamatinib
PRKDC protein kinase, DNA-activated, catalytic subunit
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • E3 ubiquitin ligases ubiquitinate target proteins
  • Caffeine
  • SF1126
PTK2 protein tyrosine kinase 2
  • Apoptotic cleavage of cellular proteins
  • Regulation of actin dynamics for phagocytic cup formation
  • Integrin signaling
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • p130Cas linkage to MAPK signaling for integrins
  • NCAM signaling for neurite out-growth
  • NCAM signaling for neurite out-growth
  • Signal regulatory protein family interactions
  • EPHB-mediated forward signaling
  • EPHB-mediated forward signaling
  • DCC mediated attractive signaling
  • DCC mediated attractive signaling
  • VEGFA-VEGFR2 Pathway
  • VEGFA-VEGFR2 Pathway
  • RHO GTPases Activate WASPs and WAVEs
  • RAF/MAP kinase cascade
  • MET activates PTK2 signaling
  • Extra-nuclear estrogen signaling
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • FCGR3A-mediated phagocytosis
  • Endostatin
  • 7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE
  • 2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE
  • Fostamatinib
PTK2B protein tyrosine kinase 2 beta
  • Signal regulatory protein family interactions
  • VEGFA-VEGFR2 Pathway
  • Interleukin-2 signaling
  • Leflunomide
  • Genistein
  • 4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide
  • Baricitinib
  • Fostamatinib
PTPN6 protein tyrosine phosphatase non-receptor type 6
  • GPVI-mediated activation cascade
  • Regulation of KIT signaling
  • PECAM1 interactions
  • Costimulation by the CD28 family
  • PD-1 signaling
  • Signal regulatory protein family interactions
  • Platelet sensitization by LDL
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • CD22 mediated BCR regulation
  • Neutrophil degranulation
  • Interferon gamma signaling
  • Regulation of IFNG signaling
  • Interleukin-37 signaling
  • Interferon alpha/beta signaling
  • Interleukin receptor SHC signaling
  • Regulation of IFNA signaling
  • Growth hormone receptor signaling
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Tiludronic acid
RGS16 regulator of G protein signaling 16
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
RPL10 ribosomal protein L10
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Peptide chain elongation
  • SRP-dependent cotranslational protein targeting to membrane
  • SRP-dependent cotranslational protein targeting to membrane
  • Viral mRNA Translation
  • Selenocysteine synthesis
  • Major pathway of rRNA processing in the nucleolus and cytosol
  • Formation of a pool of free 40S subunits
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Termination
  • Regulation of expression of SLITs and ROBOs
  • Response of EIF2AK4 (GCN2) to amino acid deficiency
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Artenimol
RPS6KB1 ribosomal protein S6 kinase B1
  • mTORC1-mediated signalling
RPS6KB2 ribosomal protein S6 kinase B2
  • AKT phosphorylates targets in the nucleus
  • Constitutive Signaling by AKT1 E17K in Cancer

Page 6 out of 7 pages